공시 • May 19
Watera, Annual General Meeting, Jun 18, 2026 Watera, Annual General Meeting, Jun 18, 2026. Location: 20 avenue gustave eiffel, gellainville France New Risk • May 11
New major risk - Revenue and earnings growth Revenue has declined by 12% over the past year. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If revenues are declining, then it is difficult for the company to prevent its earnings from declining as well. A trend of falling revenue can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-€1.7m free cash flow). Share price has been highly volatile over the past 3 months (30% average weekly change). Revenue has declined by 12% over the past year. Shareholders have been substantially diluted in the past year (213% increase in shares outstanding). Minor Risks Revenue is less than US$5m (€2.0m revenue, or US$2.4m). Market cap is less than US$100m (€22.3m market cap, or US$26.3m). 공시 • May 02
Watera to Report First Half, 2026 Results on Sep 30, 2036 Watera announced that they will report first half, 2026 results on Sep 30, 2036 New Risk • Apr 19
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (29% average weekly change). Negative equity (-€4.7k). Shareholders have been substantially diluted in the past year (213% increase in shares outstanding). Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Revenue is less than US$5m (€2.2m revenue, or US$2.6m). Market cap is less than US$100m (€23.4m market cap, or US$27.5m). New Risk • Mar 11
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of French stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Negative equity (-€4.7k). Shareholders have been substantially diluted in the past year (213% increase in shares outstanding). Minor Risks Revenue is less than US$5m (€2.2m revenue, or US$2.5m). Market cap is less than US$100m (€11.3m market cap, or US$13.1m). New Risk • Jul 21
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 7.2% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (16% average weekly change). Earnings are forecast to decline by an average of 7.2% per year for the foreseeable future. Market cap is less than US$10m (€4.40m market cap, or US$5.12m). Minor Risks Less than 3 years of financial data is available. Currently unprofitable and not forecast to become profitable over next 2 years (€3.6m net loss in 2 years). Revenue is less than US$5m (€3.0m revenue, or US$3.5m). 공시 • May 28
Osmosun S.A., Annual General Meeting, Jun 30, 2025 Osmosun S.A., Annual General Meeting, Jun 30, 2025. Location: hotel mercure paris gare montparnasse tgv, 40 rue du commandant mouchotte, place catalogne, paris France New Risk • Mar 21
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: €8.48m (US$9.17m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (15% average weekly change). Market cap is less than US$10m (€8.48m market cap, or US$9.17m). New Risk • Nov 21
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: €9.49m (US$9.94m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (14% average weekly change). Market cap is less than US$10m (€9.49m market cap, or US$9.94m). New Risk • Sep 23
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of French stocks, typically moving 7.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Share price has been volatile over the past 3 months (7.9% average weekly change). Market cap is less than US$100m (€17.9m market cap, or US$19.9m). 공시 • Oct 29
Osmosun S.A. to Report Fiscal Year 2023 Results on Apr 23, 2024 Osmosun S.A. announced that they will report fiscal year 2023 results After-Market on Apr 23, 2024 공시 • Oct 27
Osmosun S.A. to Report First Half, 2024 Results on Oct 29, 2024 Osmosun S.A. announced that they will report first half, 2024 results on Oct 29, 2024 
